CEO
COO
A strategic leader with a proven track record of operational excellence in the pharmaceutical industry and beyond. Holds a PhD in Molecular Neurobiology and an Executive MBA, bringing deep experience in drug discovery and technology licensing. Has managed teams and projects within Multiple Sclerosis, pain, epilepsy, Alzheimer’s disease, and gene therapy.
CSO
CTO
Other current positions: Chairman of the Board at FenoMark Diagnostics, Moleculent and Offspring Biosciences AB. Partner at Colibri Ventures.
Previous positions: Executive Vice President at Pharmacia, Board Member and CFO at Phadia AB, Board Member Halo Genomics AB, VP Finance & Operations at ArthroCare International.
Other current positions: Board Member, Co-owner and Investor at Scale Up Life Science Invest, Board Member at FrostPharma AB, Board Member at Sedana Medical.
Previous positions: Vice President Marketing at Olink Proteomics, VP Commercial Operations International Region at Thermo Fisher Scientific, Global Brand Director at Phadia AB, Strategic Development Manager at Pfizer.
Other current positions: Board Member at Molecular Attraction AB, Board Member at Geras Solutions, Board Member TIRmed Pharma, Investment Manager at Almi Invest
Previous positions: IP Manager at KTH Holding AB, Founder of Scanditerraneo, Business Development Coach at KTH Innovation
Other current positions: Professor of Epigenetics at the University of Oxford
Previous positions: Professor of Cell Biology and C. H. Waddington Professor of Pediatrics at Harvard Medical School, Professor of Pediatrics at Division of Newborn Medicine at Boston Children’s Hospital, Postdoc at Princeton University.
Board Member and CSO Epigenica
This website uses cookies. By continuing to use this site, you accept our use of cookies.